Viewing Study NCT02903069

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-03-08 @ 1:58 AM
Study NCT ID: NCT02903069
Status: COMPLETED
Last Update Posted: 2021-04-19
First Post: 2016-09-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
None Malignant Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None newly diagnosed View
None malignant glioma View
None WHO Grade 4 View
None WHO Grade IV View
None marizomib View
None MRZ View
None TMZ View
None RT View
None brain cancer View
None proteasome inhibitor View
None radiation View
None temozolomide View
None temodar View
None chemotherapy View
None concurrent View
None adjuvant View
None Optune View
None Novocure View
None NovoTTF View